Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,784 | -1,700 | -1,002 | -94 | -1,660 |
| Depreciation Amortization | 14 | 11 | 7 | 4 | 14 |
| Accounts receivable | -2 | 0 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | N/A | -40 | -4 | 1 | N/A |
| Other Working Capital | -43 | -43 | 1 | 15 | -31 |
| Other Operating Activity | 2,157 | 1,539 | 884 | 43 | 1,182 |
| Operating Cash Flow | $-657 | $-234 | $-113 | $-31 | $-496 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | N/A | N/A | -1 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -14 |
| Investing Cash Flow | $-1 | $-1 | $N/A | $N/A | $-15 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 28 |
| Debt Issued | 1,674 | 677 | 155 | N/A | 441 |
| Debt Repayment | -107 | N/A | N/A | N/A | -53 |
| Other Financing Activity | 41 | 7 | 4 | 0 | 26 |
| Financing Cash Flow | $1,608 | $684 | $159 | $N/A | $442 |
| Exchange Rate Effect | 0 | -1 | -1 | 1 | -6 |
| Beginning Cash Position | 41 | 41 | 41 | 41 | 115 |
| End Cash Position | 990 | 489 | 86 | 11 | 41 |
| Net Cash Flow | $950 | $449 | $46 | $-31 | $-75 |
| Free Cash Flow | |||||
| Operating Cash Flow | -657 | -234 | -113 | -31 | -496 |
| Capital Expenditure | -1 | -1 | N/A | N/A | -1 |
| Free Cash Flow | -659 | -234 | -113 | -31 | -497 |